Summary unavailable.

Questions

Question 1

What is the primary purpose of using bronchodilators like albuterol in the management of asthma or chronic obstructive pulmonary disease (COPD)?

View answer and explanation
Question 2

How do beta2-adrenergic agonists like albuterol produce bronchodilation?

View answer and explanation
Question 3

Which of the following drug classes works by inhibiting the breakdown of cyclic adenosine monophosphate (cAMP)?

View answer and explanation
Question 4

Ipratropium and tiotropium are examples of which class of bronchodilators?

View answer and explanation
Question 5

Which of the following beta2-adrenergic agonists is noted to have a delayed onset of action, making it unsuitable for managing acute attacks?

View answer and explanation
Question 6

What is a significant contraindication for the use of bronchodilators?

View answer and explanation
Question 7

The therapeutic effectiveness of bronchodilators may be antagonized by the concurrent use of which class of drugs?

View answer and explanation
Question 8

What is the minimum amount of daily liquid intake recommended for patients taking bronchodilators to help decrease the viscosity of airway secretions?

View answer and explanation
Question 9

Patients taking theophylline should be advised to minimize their intake of xanthine-containing foods and beverages because they may cause what effect?

View answer and explanation
Question 10

When a patient is using a bronchodilator and another inhalation medication, what is the recommended procedure for administration?

View answer and explanation
Question 11

What does repeated or chronic use of rapid-acting inhaled beta-agonist bronchodilators indicate for a patient with asthma?

View answer and explanation
Question 12

What is the mechanism of action for the anticholinergic compounds ipratropium and tiotropium?

View answer and explanation
Question 13

Which of the following classes of drugs may potentiate the cardiovascular effects of bronchodilators?

View answer and explanation
Question 14

According to the nursing implications, what is the recommended administration schedule for bronchodilators to maintain therapeutic plasma levels?

View answer and explanation
Question 15

In which group of patients should bronchodilators be used cautiously?

View answer and explanation
Question 16

Aminophylline and theophylline are examples of which class of bronchodilators?

View answer and explanation
Question 17

What is one of the key desired outcomes for a patient receiving bronchodilator therapy?

View answer and explanation
Question 18

Which nursing assessment is crucial for patients with a history of cardiovascular problems who are starting on bronchodilators?

View answer and explanation
Question 19

Patients on bronchodilator therapy should be advised to avoid OTC cough, cold, or breathing preparations without consulting a health care professional for what primary reason?

View answer and explanation
Question 20

Which of the following is NOT listed as a beta2-adrenergic agonist bronchodilator?

View answer and explanation
Question 21

A patient using a bronchodilator should contact their health care professional promptly if what situation occurs?

View answer and explanation
Question 22

What is the primary mechanism of action for ipratropium and tiotropium?

View answer and explanation
Question 23

Which of the following is NOT listed as a beta2-agonist with a delayed onset of action?

View answer and explanation
Question 24

What is the primary reason patients using bronchodilators are advised to avoid smoking and other respiratory irritants?

View answer and explanation
Question 25

Concurrent use of bronchodilators with antidepressants and MAO inhibitors may lead to what specific effect?

View answer and explanation
Question 26

What is the recommended time to wait after using a bronchodilator before administering another inhalation medication?

View answer and explanation
Question 27

Which class of bronchodilators includes the drugs aminophylline and theophylline?

View answer and explanation
Question 28

In the management of asthma, what are rapid-acting inhaled beta-agonist bronchodilators primarily reserved for?

View answer and explanation
Question 29

Which of the following would NOT be considered a long-term control agent indicated when repeated use of a rapid-acting bronchodilator is necessary?

View answer and explanation
Question 30

Which of the following nursing diagnoses is listed as a potential issue for patients on bronchodilators?

View answer and explanation
Question 31

Concurrent use of bronchodilators with other adrenergic drugs like decongestants results in what type of interaction?

View answer and explanation
Question 32

Which of the following assessments should be performed before and throughout bronchodilator therapy?

View answer and explanation
Question 33

What type of preservative is mentioned as a potential cause of hypersensitivity, which is a contraindication for bronchodilator use?

View answer and explanation
Question 34

What is the desired outcome related to breathing for a patient on bronchodilator therapy?

View answer and explanation
Question 35

Which of the following drugs is NOT a beta2-adrenergic agonist?

View answer and explanation
Question 36

Which condition requires cautious use of bronchodilators?

View answer and explanation
Question 37

Which of these long-acting beta2-agonists is NOT recommended for the management of acute attacks due to a delayed onset?

View answer and explanation
Question 38

What assessment of a patient's secretions should be made before and during bronchodilator therapy?

View answer and explanation
Question 39

Which potential nursing diagnosis is mentioned as being related to the patient's physical response to breathing difficulties?

View answer and explanation
Question 40

What patient advice helps manage the side effects of theophylline?

View answer and explanation
Question 41

Beta2-adrenergic agonists like epinephrine produce bronchodilation by stimulating the production of what substance?

View answer and explanation
Question 42

What is the consequence of concurrent use of bronchodilators and beta blockers?

View answer and explanation
Question 43

What is the recommended minimum daily fluid intake for a patient taking bronchodilators?

View answer and explanation
Question 44

If a patient taking theophylline reports consuming large amounts of coffee and chocolate, what is the most likely consequence?

View answer and explanation
Question 45

Which of the following agents is an anticholinergic compound used as a bronchodilator?

View answer and explanation
Question 46

Why should patients with a history of cardiovascular problems be closely monitored with an ECG while on bronchodilator therapy?

View answer and explanation
Question 47

What is the recommended action if a patient vomits after taking an oral dose of theophylline?

View answer and explanation
Question 48

According to the text, which drug class works by inhibiting the breakdown of cAMP, thus acting as a bronchodilator?

View answer and explanation
Question 49

Which of the following is an example of an oral long-acting bronchodilator mentioned as a long-term control agent?

View answer and explanation
Question 50

A patient is advised to use their bronchodilator inhaler first, followed by their corticosteroid inhaler. How long should they wait between using the two inhalers?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations